Richman Chemical Inc. has announced the commercial launch of Technology Assessment Reports (TARs) to help companies and tech transfer offices evaluate innovations for commercial potential. The TARs will provide users with cost-effective production improvement strategies and tips to streamline commercialization.
“University and nonprofit technology transfer offices represent a significant market for such reports,” says Christopher Kulp, executive vice president at Richman Chemical. “These entities seek to license in-house technology to outside companies and investors, yet do not have the resources or expertise to evaluate commercial feasibility.
“Meanwhile,” Kulp says, “potential investors and partners prefer independent analysis that a technology is commercially viable before making the decision whether to invest. Almost all start-up firms in the chemical and life science industries face similar challenges in developing and successfully commercializing their technologies.”
The TAR conducts needs analysis, identifies process efficiencies and deficiencies, and helps project leaders effectively select and allocate their limited resources. For example, the choices of reagents and intermediates are evaluated for performance, cost and availability. According to Richman Chemical, the reports are offered at reasonable, fixed-bid price points and can be customized to accommodate specific budget and content requests.